Aeterna Zentaris Inc (NASDAQ:AEZS)

0.3372
Delayed Data
As of 3:54pm ET
 -0.0018 / -0.53%
Today’s Change
0.33
Today|||52-Week Range
3.62
-5.09%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$43.3M

Company Description

Æterna Zentaris, Inc. operates as a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests. Its product Macimorelin, is an oral growth hormone secretagogue receptor agonist indicated for the diagnosis of Adult Growth Hormone Deficiency. The company was founded on September 12, 1990 and is headquartered in Charleston, SC.

Contact Information

Æterna Zentaris, Inc.
315 Sigma Drive
Charleston South Carolina 29486
P:(843) 900-3223
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Klaus Wolfgang PauliniPresident, Chief Executive Officer & Director
Leslie AuldChief Financial Officer & Senior Vice President
Michael TeifelChief Scientific Officer
Nicola AmmerChief Medical Officer & VP-Clinical Development
Matthias GerlachVice President-Manufacturing & Supply Chain